Phenothiazine therapy and plasma immunoreactive beta-MSH in schizophrenia and pruritic dermatoses.
Plasma immunoreactive beta-melanocyte-stimulating hormone (beta-MSH) concentrations were normal in schizophrenic patients on prolonged and high dosage phenothiazine therapy. A group of patients treated with chlorpromazine 25 mg three times daily for pruritic dermatoses also showed no significant change in plasma beta-MSH concentration.
D000293:Adolescent; D000328:Adult; D002746:Chlorpromazine / Q000494:pharmacology / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D009074:Melanocyte-Stimulating Hormones / Q000097:blood / Q000378:metabolism*; D008875:Middle Aged; D010640:Phenothiazines / Q000494:pharmacology / Q000627:therapeutic use*; D011537:Pruritus / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology; D012559:Schizophrenia / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology
D010640:Phenothiazines; D009074:Melanocyte-Stimulating Hormones; D002746:Chlorpromazine